Eli Lilly, Lycia Collaborate to Discover Targeted Drug Candidates
Eli Lilly and Company recently entered into a multi-year research collaboration and licensing agreement with Lycia Therapeutics to discover, deliver, and commercialize novel targeted drug...Bayer Enters Pharma Acquisition Deal for Undruggable Targets
Bayer recently entered into a pharma acquisition deal with Vividion Therapeutics to unlock high value, traditionally undruggable targets with precision therapeutics. Vividion will leverage its...Eli Lilly, Kumquat to Discover Drug Candidates for Tumors
Eli Lilly and Company and Kumquat Biosciences recently entered into a multi-year collaboration to discover, develop, and commercialize potential small molecule drug candidates that stimulate...Amgen Enters Pharma Acquisition Deal to Develop New Biologics
Amgen recently entered into a pharmaceutical acquisition deal with Teneobio to discover and develop new biologics to treat various diseases across Amgen’s therapeutic areas. Teneobio is a...AstraZeneca, Regeneron to Develop Drug Candidates to Treat Obesity
AstraZeneca recently entered into a collaboration with Regeneron to research, develop, and commercialize small molecule drug candidates to treat obesity and related co-morbidities. Specifically,...Biogen’s Alzheimer’s Disease Drug Safe, Effective in Trial
Biogen recently announced that its Alzheimer’s disease drug, BIIB080, was safe and well-tolerated in patients with mild disease. The drug was developed in partnership with Ionis...Biden Invests Over $3B to Boost COVID-19 Antiviral Development
The Biden Administration will invest over $3 billion to accelerate the discovery, development, and manufacturing of COVID-19 antiviral medicines. The initiative, called the Antiviral Program for...Understanding Basic Principles of Pharmaceutical Drug Discovery
Drug discovery is a crucial part of the drug development pipeline, beginning with the identification of a disease target to the creation of lead compounds. According to Amanda Garner, PhD, Associate...Thermo Fisher, UCSF Boost Manufacturing of Cell-Based Therapies
Thermo Fisher Scientific and the University of California (UCSF) recently formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. Under the terms of...Eli Lilly Taps saRNA Research Tech from MiNA for Drug Discovery
Eli Lilly and Company and MiNA Therapeutics recently entered into a global research collaboration that will leverage small activating RNA (saRNA) research technology for drug discovery. MiNA...AI in the Pharma Industry: Current Uses, Best Cases, Digital Future
Pharmaceutical executives are looking for ways to leverage artificial intelligence and machine learning within the healthcare and the biotech industry. Reports show an increasing number of entities are...Early COVID-19 Treatments Elicited No Real Benefits in Patients
A JAMA Network Open study found that COVID-19 treatments hydroxychloroquine and lopinavir-ritonavir failed to show any significant benefit in hospitalized patients. The study analyzed metrics such...Sponsored by Pure Storage
